Nemaura Medical Inc. (NMRD)

$2.1

-0.10 (-4.55%)
Rating:
Recommendation:
Buy
Symbol NMRD
Price $2.1
Beta 0.133
Volume Avg. 0.01M
Market Cap 50.616M
Shares () -
52 Week Range 2.0-9.68
1y Target Est -
DCF Unlevered NMRD DCF ->
DCF Levered NMRD LDCF ->
ROE -599.81% Strong Sell
ROA -93.78% Strong Sell
Operating Margin -
Debt / Equity 4642.05% Strong Buy
P/E -
P/B 0 Neutral
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest NMRD news


Dr. Dewan Chowdhury
Healthcare
Medical Devices
NASDAQ Capital Market

Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.